APA (7th ed.) Citation

Lambidis, E., Chen, C., Baikoghli, M., Imlimthan, S., Khng, Y. C., Sarparanta, M., . . . Airaksinen, A. J. (2022). Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET. Molecular pharmaceutics, 19(8), 2971-2979. https://doi.org/10.1021/acs.molpharmaceut.2c00359

Chicago Style (17th ed.) Citation

Lambidis, Elisavet, Chun-Chieh Chen, Mo Baikoghli, Surachet Imlimthan, You Cheng Khng, Mirkka Sarparanta, R. Holland Cheng, and Anu J. Airaksinen. "Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET." Molecular Pharmaceutics 19, no. 8 (2022): 2971-2979. https://doi.org/10.1021/acs.molpharmaceut.2c00359.

MLA (9th ed.) Citation

Lambidis, Elisavet, et al. "Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET." Molecular Pharmaceutics, vol. 19, no. 8, 2022, pp. 2971-2979, https://doi.org/10.1021/acs.molpharmaceut.2c00359.